trending Market Intelligence /marketintelligence/en/news-insights/trending/iCZlE4bnGaZk41QiqbzMIQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

In This List

Phio Pharmaceuticals approves reverse stock split at 1-for-55 ratio

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Phio Pharmaceuticals approves reverse stock split at 1-for-55 ratio

Phio Pharmaceuticals Corp.'s board has approved a reverse stock split of the company's shares at a 1-for-55 ratio.

The Marlborough, Mass.-based biotechnology company hopes to maintain compliance with the Nasdaq's $1 minimum bid price listing requirement through the reverse split.

Every 55 shares of the company will be split into one, bringing the issued and outstanding shares from about 36.8 million to approximately 670,000.

The reverse split will be effective Jan. 15, and the company's stock will resume trading on the same day.

Computershare Trust Co. NA will be the transfer agent for the reverse stock split.